It wasn’t until the 1930s, when scientists first demonstrated that rats that ate drastically less tended to live longer, that ...

Successful 2024 marked by significant clinical advancements across Oculis' late-stage and highly differentiated clinical ...

Even lower doses of Ethambutol can Induce Optic Neuropathy, suggests a study published in the Cureus.The present study aims ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Neuro-ophthalmology focuses on diseases that affect the optic nerve and the visual pathways. Due to the complexity of the ...

Two large studies from the University of Southern Denmark (SDU) have found that Ozempic, a widely used medication for type 2 ...

This paper reviews the latest progress in the application of AI technologies such as machine learning (ML) and deep learning (DL) in ophthalmic diseases.

Optic neuropathy and recurrence of papilledema in patients with craniosynostosis may be a clinically useful biomarker by PHOMS.

Ocugen (OCGN) announced that alignment has been reached with the FDA to move forward with a Phase 2/3 pivotal confirmatory clinical trial for ...

Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with ...

WEDNESDAY, Feb. 26, 2025 (HealthDay News) -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy ...